Short interest in Cartesian Therapeutics Inc (NASDAQ:RNAC) increased during the last reporting period, rising from 811.44K to 1.15M. This put 20.67% of the company's publicly available shares short.

Short interest for Cartesian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cartesian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 159.77K shares traded per day, it would take 7.22 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.